Biomedtracker (including Enhanced Company Deals Upgrade)
Closed Solicitation Posted
- Solicitation number
- 75N95024Q00344
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 513210 Software Publishers
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health intends to negotiate a sole source contract with Citeline/Caerus US 1 Inc. to provide five one-year licenses for Biomedtracker and five one-year licenses for an Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a database of pharmaceutical information, including chemicals, royalties, deals, companies, and other data. NCATS requires the ability to export this data into Excel and access expert analyst support. The contract will be awarded under FAR Part 13 Simplified Acquisition Procedures, which allows for sole source procurements when only one source can meet the requirements.
This acquisition is classified under NAICS code 513210 for Software Publishers, with a $47 million size standard. The anticipated period of performance is June 24, 2024 to June 23, 2025, and the estimated value is $26,870. Interested parties may submit capability statements, proposals, or quotations by the June 24, 2024 deadline. This is not a request for competitive proposals, but the government will consider all responsible sources.
Notice text
NOTICE OF INTENT to Sole Source
SOLICITATION NUMBER: 75N95024Q00344
TITLE: Biomedtracker (including Enhanced Company Deals Upgrade)
CLASSIFICATION CODE: DA10 IT and Telecom - Business Applicaiton/Application Development Software as a Service
NAICS CODE: 513210 – Software Publishers
RESPONSE DATE:
June 24, 2024 at 11:00 AM EST
PRIMARY POINT OF CONTACT:
Michelle Cecilia
michelle.cecilia@nih.gov
Phone: 301.827.7199
DESCRIPTION:
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with Citeline to provide one year licenses for Enhanced Company and Deals Upgrade Licenses (5) and Biomedtracker (5).
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS
The intended procurement is classified under NAICS code 513210 – Business Size Standard $47 million.
REGULATORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2024-05 dated May 22, 2024.
DESCRIPTION OF REQUIREMENT
The National Center for Advancing Translational Science (NCATS) Office of Strategic Alliances (OSA) works to support collaboration between academic research institutions and scientific pharmacological industry organizations. OSA works in particular to address intellectual property (IP) issues by reviewing and tracking new innovations and developing strategies for patent filing and partnering. NCATS OSA therefore requires software tools to conduct research on innovations and technology development related to NCATS research.
PURPOSE AND OBJECTIVES:
The NCATS OSA requires five (5) one-year software licenses for a single-platform database providing access to pharmaceutical information as well as associated companies, patents, technologies, and agreements
SPECIFIC REQUIREMENTS:
NCATS would like access to reporting tools for chemical structures, royalties, milestones, epidemiology, and sales. The database should be able to export the requested information into excel, we would like to see columns such as deals, companies, products, mechanism of action, class, deal value, and upfront cash. If possible OSA would like to have access to online support expert analyst who can answer questions about products, sales, deals, mergers, venture capital investments and partnerships.
Anticipated Period of Performance:
Base: 6/24/2024 – 6/23/2025
CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION
The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Citeline’s Biomedtracker and Enhanced Company and Deals Upgrade line of products is only available from Citeline. In fact, Citeline is the only vendor in the marketplace that can provide the software licenses that provide the meet the requirement in the purchase description for NCATS.
The intended source is:
Citeline/Caerus US 1 Inc.
One Pennsylvania Plaza, Suite 2505
New York, NY 10119
CLOSING STATEMENT
THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by the closing date and time of this announcement and must reference the solicitation number 75N95024Q00344. Responses must be submitted electronically to Michelle Cecilia, Contracting Officer, at michelle.cecilia@nih.gov. U.S. Mail and fax responses will not be accepted.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| Access to Web of Science, EndNote and Incites | Office of Logisitics and Acquisition Operations | No set-aside | |
| ASIT. TO 1 year software support from ArgonSoft (Notice of Intent to sole source) | NIH Clinical Center | No set-aside | |
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity